STOCK TITAN

Director Daphne Karydas receives 21,110 CMPS options at $11.85 strike

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

COMPASS Pathways plc director Daphne Karydas received a grant of share options covering 21,110 ordinary shares. These options have an exercise price of $11.85 per share and were awarded at no cost as a compensation grant.

The options vest in full on the earlier of the first anniversary of the grant date or the company’s 2027 Annual General Meeting of Shareholders, and they expire in 2036. Each ordinary share may be represented by one American Depositary Share.

Positive

  • None.

Negative

  • None.
Insider Karydas Daphne
Role null
Type Security Shares Price Value
Grant/Award Share Option (Right to Buy) 21,110 $0.00 --
Holdings After Transaction: Share Option (Right to Buy) — 21,110 shares (Direct, null)
Footnotes (1)
  1. The shares underlying this option vest in full upon the earlier to occur of (i) the first anniversary of the date of grant or (ii) the date of COMPASS Pathways plc's Annual General Meeting of Shareholders in 2027. The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.
Options granted 21,110 options Share Option (Right to Buy) granted to director
Exercise price $11.85 per share Conversion or exercise price of options
Shares after transaction 21,110 derivative securities Total share options held following transaction
Underlying shares 21,110 ordinary shares Ordinary shares underlying granted options
Vesting trigger First anniversary or 2027 AGM Options vest in full at earliest of these dates
Expiration date May 26, 2036 Final date to exercise the options
Share Option (Right to Buy) financial
"security_title: "Share Option (Right to Buy)""
exercise price financial
"conversion_or_exercise_price: "11.8500""
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
vest in full financial
"The shares underlying this option vest in full upon the earlier to occur"
Annual General Meeting of Shareholders regulatory
"the date of COMPASS Pathways plc's Annual General Meeting of Shareholders in 2027"
American Depositary Shares financial
"The Ordinary Shares may be represented by American Depositary Shares"
American depositary shares (ADSs) are a way for investors in the United States to buy shares of foreign companies without dealing with international markets directly. They represent ownership in a foreign company's stock and are traded on U.S. stock exchanges, making it easier for American investors to buy, sell, and own parts of companies from around the world.
See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Karydas Daphne

(Last)(First)(Middle)
C/O COMPASS PATHWAYS PLC
33 BROADWICK STREET

(Street)
LONDONW1F 0DQ

(City)(State)(Zip)

UNITED KINGDOM

(Country)
2. Issuer Name and Ticker or Trading Symbol
COMPASS Pathways plc [ CMPS ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
Officer (give title below)Other (specify below)
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
05/27/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Share Option (Right to Buy)$11.8505/27/2026A21,11005/27/2027(1)05/26/2036Ordinary Shares(2)21,110$021,110D
Explanation of Responses:
1. The shares underlying this option vest in full upon the earlier to occur of (i) the first anniversary of the date of grant or (ii) the date of COMPASS Pathways plc's Annual General Meeting of Shareholders in 2027.
2. The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.
Remarks:
/s/ Meredith Prithviraj by Power of Attorney for Daphne Karydas05/29/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What did Daphne Karydas acquire in the latest CMPS Form 4 filing?

Daphne Karydas received a grant of options over 21,110 ordinary shares of COMPASS Pathways. The options were awarded as compensation at a $11.85 exercise price and increase her direct derivative holdings in the company.

What is the exercise price of Daphne Karydas’s new CMPS share options?

The new options granted to Daphne Karydas have an exercise price of $11.85 per share. This is the price she must pay to convert each option into an ordinary share when the options become exercisable and before they expire.

When do Daphne Karydas’s CMPS options vest according to the Form 4?

The options vest in full on the earlier of the first anniversary of the grant date or the date of COMPASS Pathways’ 2027 Annual General Meeting of Shareholders. After vesting, she can exercise them anytime before expiration.

When do the share options granted to Daphne Karydas expire?

The options granted to Daphne Karydas expire on May 26, 2036. She must exercise any vested options before this expiration date; after that, any unexercised options will lapse and can no longer be converted into shares.

How many COMPASS Pathways shares are underlying Daphne Karydas’s new options?

The grant covers 21,110 underlying ordinary shares of COMPASS Pathways. Each option corresponds to one ordinary share, and each ordinary share may also be represented by one American Depositary Share in the U.S. market.

How many derivative securities does Daphne Karydas hold after this CMPS Form 4 transaction?

Following the grant, Daphne Karydas holds 21,110 share options as reported in the filing. These options are held directly and represent potential future ownership of the same number of ordinary shares, subject to vesting and exercise.